These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Stocks in Asia were set to trade lower on Monday, while investors await the launch of a Nasdaq-style technology board on the Shanghai Stock Exchange.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
Gluskin Sheff's David Rosenberg is painting a painful picture for stocks as earnings season goes into full gear.Futures Nowread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
The two companies are scheduled to meet Assistant Attorney General William Baer Friday to discuss "significant concerns" with the deal, reported trade publication MLex, citing unnamed sources.
The regulators' concerns are focused on whether the deal will limit consumer choices for Medicare Advantages health plans for the elderly, according to reports.
The Justice Department declined CNBC's request for comment on the report. A Humana spokesperson wasn't immediately available.
"We continue to cooperate with the Department of Justice on its review," an Aetna spokesman told CNBC.
"Meetings with Bill Baer are generally regarded as negative," said Ira Gorsky, an analyst at Elevation Securities, in a research note. "It may be interpreted as Aetna being unable to adequately address the staff's concerns at this point, which increases the chance of litigation."
This meeting with Baer comes two weeks after he met with rivals Anthem and Cigna about their merger plans. According to the MLex report, the DOJ's top antitrust regulator told the companies that he backed the staff's conclusion that the merger would reduce competition in the employer market, and that divestitures weren't likely to remedy those concerns. The report did not cite its source for the information.
Stifel analyst Thomas Carroll said it makes sense that Aetna and Humana are meeting with regulators, saying it is likely getting close to the end of the review process and it makes sense that they may have been asked about divestitures and are now negotiating what would be acceptable.
"The process to review Aetna-Humana is simple when compared to Anthem-Cigna, " he said, explaining that their one area of overlap is Medicare. "It's primarily one product — Medicare Advantage and Medicare Part D. Market share data is readily available, so it should be much more objective."
While there has been greater concern that the Anthem-Cigna deal would be blocked, the reports cast some new worries about the Aetna-Cigna combination.
The DOJ process may be "at this binary point" where the insurance deals could be blocked, Gorsky said.
Aetna said a year ago that it planned to buy Humana for about $37 billion, in what would be the industry's largest deal ever. Recent media reports have speculated that Aetna was preparing to sell billions in assets to quiet antitrust concerns in markets where the two companies have overlap.
A proposed merger between insurers Anthem and Cigna is also under review by regulators.
Humana closed at $162.74 on Thursday. The stock has fallen nearly 9 this year.
HUM 2016 Chart